Sign in Subscribe

stage-i-ii

A collection of 37 issues

Phase III trial shows circulating tumor DNA methylation monitoring can guide postoperative surveillance in nonmetastatic colorectal cancer

Skip to content The CRC Digest ◆ TRIAL DATA Phase III trial shows circulating tumor DNA methylation monitoring can guide postoperative surveillance in nonmetastatic colorectal cancer The prospective, randomized FIND trial used dynamic ctDNA methylation monitoring to personalize follow-up care after surgery in stage I-III patients. (Journal of Clinical Oncology) This

Subscribe to The CRC Digest

Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe

The CRC Digest provides research summaries for informational and educational purposes only.
This is not medical advice. Always consult your healthcare provider before making any decisions about your care.

Disclaimer Privacy Policy Terms of Use About